253 related articles for article (PubMed ID: 10931418)
1. Calcium-stimulated insulin secretion in diffuse and focal forms of congenital hyperinsulinism.
Ferry RJ; Kelly A; Grimberg A; Koo-McCoy S; Shapiro MJ; Fellows KE; Glaser B; Aguilar-Bryan L; Stafford DE; Stanley CA
J Pediatr; 2000 Aug; 137(2):239-46. PubMed ID: 10931418
[TBL] [Abstract][Full Text] [Related]
2. Preoperative evaluation of infants with focal or diffuse congenital hyperinsulinism by intravenous acute insulin response tests and selective pancreatic arterial calcium stimulation.
Stanley CA; Thornton PS; Ganguly A; MacMullen C; Underwood P; Bhatia P; Steinkrauss L; Wanner L; Kaye R; Ruchelli E; Suchi M; Adzick NS
J Clin Endocrinol Metab; 2004 Jan; 89(1):288-96. PubMed ID: 14715863
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of insulin secretion in children with congenital hyperinsulinism due to sulfonylurea receptor mutations.
Grimberg A; Ferry RJ; Kelly A; Koo-McCoy S; Polonsky K; Glaser B; Permutt MA; Aguilar-Bryan L; Stafford D; Thornton PS; Baker L; Stanley CA
Diabetes; 2001 Feb; 50(2):322-8. PubMed ID: 11272143
[TBL] [Abstract][Full Text] [Related]
4. Genotype-phenotype correlations in children with congenital hyperinsulinism due to recessive mutations of the adenosine triphosphate-sensitive potassium channel genes.
Henwood MJ; Kelly A; Macmullen C; Bhatia P; Ganguly A; Thornton PS; Stanley CA
J Clin Endocrinol Metab; 2005 Feb; 90(2):789-94. PubMed ID: 15562009
[TBL] [Abstract][Full Text] [Related]
5. Suppression of insulin oversecretion by subcutaneous recombinant human insulin-like growth factor I in children with congenital hyperinsulinism due to defective beta-cell sulfonylurea receptor.
Katz LE; Ferry RJ; Stanley CA; Collett-Solberg PF; Baker L; Cohen P
J Clin Endocrinol Metab; 1999 Sep; 84(9):3117-24. PubMed ID: 10487673
[TBL] [Abstract][Full Text] [Related]
6. Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia.
Verkarre V; Fournet JC; de Lonlay P; Gross-Morand MS; Devillers M; Rahier J; Brunelle F; Robert JJ; Nihoul-Fékété C; Saudubray JM; Junien C
J Clin Invest; 1998 Oct; 102(7):1286-91. PubMed ID: 9769320
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular characterization of a dominant form of congenital hyperinsulinism caused by a mutation in the high-affinity sulfonylurea receptor.
Thornton PS; MacMullen C; Ganguly A; Ruchelli E; Steinkrauss L; Crane A; Aguilar-Bryan L; Stanley CA
Diabetes; 2003 Sep; 52(9):2403-10. PubMed ID: 12941782
[TBL] [Abstract][Full Text] [Related]
8. [Congenital hyperinsulinism in newborn and infant].
Giurgea I; Ribeiro MJ; Boddaert N; Touati G; Robert JJ; Saudubray JM; Jaubert F; Bellanné-Chantelot C; Brunelle F; Nihoul-Fékété C; de Lonlay P
Arch Pediatr; 2005 Nov; 12(11):1628-35. PubMed ID: 16198094
[TBL] [Abstract][Full Text] [Related]
9. Congenital hyperinsulinism associated ABCC8 mutations that cause defective trafficking of ATP-sensitive K+ channels: identification and rescue.
Yan FF; Lin YW; MacMullen C; Ganguly A; Stanley CA; Shyng SL
Diabetes; 2007 Sep; 56(9):2339-48. PubMed ID: 17575084
[TBL] [Abstract][Full Text] [Related]
10. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1.
Huopio H; Reimann F; Ashfield R; Komulainen J; Lenko HL; Rahier J; Vauhkonen I; Kere J; Laakso M; Ashcroft F; Otonkoski T
J Clin Invest; 2000 Oct; 106(7):897-906. PubMed ID: 11018078
[TBL] [Abstract][Full Text] [Related]
11. Histopathology of congenital hyperinsulinism: retrospective study with genotype correlations.
Suchi M; MacMullen C; Thornton PS; Ganguly A; Stanley CA; Ruchelli ED
Pediatr Dev Pathol; 2003; 6(4):322-33. PubMed ID: 14692646
[TBL] [Abstract][Full Text] [Related]
12. Acute insulin responses to calcium and tolbutamide do not differentiate focal from diffuse congenital hyperinsulinism.
Giurgea I; Laborde K; Touati G; Bellanné-Chantelot C; Nassogne MC; Sempoux C; Jaubert F; Khoa N; Chigot V; Rahier J; Brunelle F; Nihoul-Fékété C; Dunne MJ; Stanley C; Saudubray JM; Robert JJ; de Lonlay P
J Clin Endocrinol Metab; 2004 Feb; 89(2):925-9. PubMed ID: 14764815
[TBL] [Abstract][Full Text] [Related]
13. Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozygosity of a mutation in ABCC8 or KCNJ11.
Fournet JC; Mayaud C; de Lonlay P; Gross-Morand MS; Verkarre V; Castanet M; Devillers M; Rahier J; Brunelle F; Robert JJ; Nihoul-Fékété C; Saudubray JM; Junien C
Am J Pathol; 2001 Jun; 158(6):2177-84. PubMed ID: 11395395
[TBL] [Abstract][Full Text] [Related]
14. Serum glucagon counterregulatory hormonal response to hypoglycemia is blunted in congenital hyperinsulinism.
Hussain K; Bryan J; Christesen HT; Brusgaard K; Aguilar-Bryan L
Diabetes; 2005 Oct; 54(10):2946-51. PubMed ID: 16186397
[TBL] [Abstract][Full Text] [Related]
15. Loss of imprinted genes and paternal SUR1 mutations lead to hyperinsulinism in focal adenomatous hyperplasia.
Fournet JC; Verkarre V; De Lonlay P; Rahier J; Brunelle F; Robert JJ; Nihoul-Fékété C; Saudubray JM; Junien C
Ann Endocrinol (Paris); 1998; 59(6):485-91. PubMed ID: 10189991
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of neonatal hyperinsulinism.
Giurgea I; Bellanné-Chantelot C; Ribeiro M; Hubert L; Sempoux C; Robert JJ; Blankenstein O; Hussain K; Brunelle F; Nihoul-Fékété C; Rahier J; Jaubert F; de Lonlay P
Horm Res; 2006; 66(6):289-96. PubMed ID: 17003566
[TBL] [Abstract][Full Text] [Related]
17. The Knudson's two-hit model and timing of somatic mutation may account for the phenotypic diversity of focal congenital hyperinsulinism.
Giurgea I; Sempoux C; Bellanné-Chantelot C; Ribeiro M; Hubert L; Boddaert N; Saudubray JM; Robert JJ; Brunelle F; Rahier J; Jaubert F; Nihoul-Fékété C; de Lonlay P
J Clin Endocrinol Metab; 2006 Oct; 91(10):4118-23. PubMed ID: 16882742
[TBL] [Abstract][Full Text] [Related]
18. Hyperinsulinism: molecular aetiology of focal disease.
Ryan F; Devaney D; Joyce C; Nestorowicz A; Permutt MA; Glaser B; Barton DE; Thornton PS
Arch Dis Child; 1998 Nov; 79(5):445-7. PubMed ID: 10193261
[TBL] [Abstract][Full Text] [Related]
19. Congenital hyperinsulinism: molecular basis of a heterogeneous disease.
Meissner T; Beinbrech B; Mayatepek E
Hum Mutat; 1999; 13(5):351-61. PubMed ID: 10338089
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of 52 neonates with hyperinsulinism.
de Lonlay-Debeney P; Poggi-Travert F; Fournet JC; Sempoux C; Dionisi Vici C; Brunelle F; Touati G; Rahier J; Junien C; Nihoul-Fékété C; Robert JJ; Saudubray JM
N Engl J Med; 1999 Apr; 340(15):1169-75. PubMed ID: 10202168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
